(Received for publication November 9, 1990) Restricticin (1) is a naturally-occurring antifungal agent which contains triene, pyran and glycine ester functionalities and is unrelated to any previously known family of natural products. This unstable compound, as well as its corresponding 7V,./V-dimethyl derivative (2) , have been produced and isolated from both solid and liquid fermentations of Penicillium restrictum. The desglycyl hydrolysis product, restrictinol (3) , was produced via the hydrolysis of pure restricticin and as an artifact of the isolation of restricticin.
Naturally-occurring antibiotics are often notoriously unstable, as illustrated by the antibacterial agent thienamycin^and the antifungal triyne carbonate2~5), which literally self-destruct upon concentration. Although steps to minimize the decomposition of unstable compoundsmay be determined empirically before isolation and structure determination, often times pure material generated via a "brute force" isolation is used to determine the structure. This structure can then suggest possible points of instability, which in turn suggest modifications in the isolation. The isolation that evolves based on structure/stability information can be radically different from the originally developed method as is well illustrated by the isolation procedures of restricticin (1)6), described in the following paper. This paper also describes the producing organism, as well as fermentation studies in solid and submerged fermentation media. A full description of the structural elucidation of these compoundswill be described elsewhere7).
Materials and Methods

Identification
of the Producing Strain The strain of Penicillium restrictum Gilman & Abbott (ATCC 20927, MF 5261) was recovered by conventional dilution plating of a soil sample collected in Tamil Nadu, India. The strain was identified using the procedure of Pftt8); in addition, its morphological features conformed well with descriptions provided by Ramirez9) and Domsch et al. 10) . Capitalized color in the description names are from Ridgway1 1*.
Solid Fermentation
The contents of one vial (containing approximately 2ml frozen vegetative mycelial cells of ATCC20927, MF5261) were inoculated into a 250-ml Erlenmeyer flask containing 50ml of the following medium (I): corn steep liquor, 5g; tomato paste, 40g; oat flour, lOg; glucose, lOg; and trace elements mix, 10ml in 1 liter of distilled water. The trace element mix contained FeSO4-7H2O 1.0g, MnSO4-4H2O l g, CuCl2-2H2O 0.025g, ZnSO4-7H2O 0.2g, CaCl2-2H2O 0.1 g, H3BO3 0.06g, (NH4)6Mo7O24-4H2O 0.019 g in 1 liter distilled water. The pH of the medium was adjusted to 6.8 and autoclaved for 20 minutes at 121°C and allowed to cool to room temperature prior to inoculation. The culture was incubated at 27°C on a rotary shaker, 220rpmfor 72 hours. Ten ml of this culture was used to inoculate a second stage seed flask containing 500ml of the same seed medium in a 2-liter Erlenmeyer flask. The second stage seed was cultivated at 27°C, 200rpm for 48 hours. Fermentation was performed in a solid production medium(contained in 6.5 cm x 13 cm x 43 cm plastic trays with lids) and consisted of the following: cracked corn 480 g, and nutrient solution 720 ml (containing yeast extract 33.3 g, sodium tartrate 6.7g, FeSO4-7H2O 0.67g in 1 liter distilled water). The medium was autoclaved for 20minutes at 121°C, followed by the addition of 500ml H2Oand a second autoclaving for 20minutes at 121°C.
After cooling, each tray was inoculated with 50 ml of the seed culture, which was distributed throughout the solid matrix by mixing the contents mixed with a sterile spatula. Fermentation trays were incubated (covered) at 26°C for 14 days without agitation.
Submerged Fermentation
The contents of one vial (containing approximately 2ml frozen vegetative mycelial cells of ATCC 20927, MF 5261) were inoculated into a 250-ml Erlenmeyer flask containing 50ml of medium I. This culture was incubated at 26°C on a gyrotory shaker at 220rpm for 48 hours.
An aliquot (7.5 ml) of this fermentation was used to inoculate a 2-liter Erlenmeyer flask containing 500ml of meidum I. This second stage seed fermentation was incubated at 26°C, 220rpm, for 48 hours.
Four 2 liters seed flasks were used to inoculate a 300-liter agitated fermentor charged with 180liters of mediumI. The medium had a presterile pH of 7 and was sterilized for 25 minutes at 122°C. This third stage seed fermentation was incubated for 36 hours at 26°C with air flow 0.3 v/v/m, back pressure 0.6 kg/cm2 and agitation speed 200 rpm.
The production mediumcontained Cerelose 50g, yellow corn meal lOg, pectin lOg, glycerol 10g, tomato paste 5g, ammonium sulfate 2g, sodium citrate 2g, glycine 2g, cod liver oil 2g, CoCl2-6H2O0.01 g, and P-2000 polyglycol 3ml in 1-liter of distilled water. The presterile pH was 7. The medium was batch sterilized for 35 minutes at 122°C, except for the Cerelose, which was sterilized separately and added aseptically to the sterilized production medium prior to inoculation. A 5%inoculum from the third stage seed was employed to inoculate three 1,400-liter-scale production fermentations (pH 4.0~4.5). The culture was incubated at 26°C for 138 hours, air flow 0.3 v/v/m, back pressure 0.6kg/cm2 and agitation speed 180 rpm.
Antifungal, TLC and HPLC Assays Disk diffusion assays on MY092{Candida albicans) were utilized, along with TLCand HPLC, to follow the original isolation of restricticin (1) .
TLCchromatograms were performed on E. Merck Silica gel 60F254 pre-coated 5cm x 10cm plates and were visualized via UV, iodine vapors or charring with phosphomolybdate.
HPLCanalysis was performed on a system consisting ofa Spectraphysics 8700 pump, a Spectraphysics 8780 autoinjector or a Waters U6Kmanual injector, a DuPont Zorbax ODS, DuPont Zorbax RX or WhatmanODS34.6mmi.d. x 25cm column, an LKB2151 variable wavelength UVdetector equipped with a 10 mmpathlength cell and a Spectraphysics 4200 integrator. Column temperature was maintained constant at 40°C via jacketing and a constant temperature water bath. The flow rate was 1 ml/minute and the UVof the effluent was monitored at 276nmand an attenuation of 0.64 aufs.
Spectroscopic Methods
NMRspectra were recorded on Varian XL-400 or XL-300 NMRspectrometers. *H NMRwere recorded in CD2C12at ambient temperature using the solvent peak at S 5.32 as an internal reference down field of TMSat O ppm. 13C NMRwere recorded in CD2C12at ambient temperature where chemical VOL.44 NO.5 THE JOURNAL OF ANTIBIOTICS 465 shifts are given in ppm down field of TMSusing the solvent peak at 53.8ppm as an internal reference. EI-MSwere obtained on a Finnigan MAT-212 mass spectrometer. IR absorption spectra were obtained with a Perkin-Elmer model 1750 IR FT spectrophotometer using a multiple internal reflectance cell (MIR, ZnSe) on neat 10-20^samples. The UV absorption spectra were measured with a Beckman DU-70 spectrophotometer.
Isolation and Physical Characterization of Restricticin (1) from Solid Fermentation A solid fermentation consisting of 10 trays was first wetted with 300ml MeOH/tray, to facilitate removal from the tray, and an additional 17 liters of MeOH was added after removal for a total of 20 liters. This suspension was stirred for 10~15 minutes and then vacuumfiltered to produce 14 liters of MeOHextract filtrate (237 g total solids).
The extract filtrate was diluted with 4.2 liters of water and partitioned with 14 liters CH2C12. The 12-liter lower layer was removed, dried over Na2SO4, filtered and concentrated under vacuum to a volume of 1.44 liters (4.7g total solids). This concentrate was stored at -80°C to slow decomposition.
Five hundred ml of this CH2C12concentrate was taken to dryness and reconstituted with 40ml Final purification was accomplished via preparative HPLCon a DuPont Zorbax ODS21.2mm i.d. x 25cm column. An isocratic solvent system (MeOH-0.01 m potassium phosphate buffer pH 7, 70 : 30) was utilized with a flow rate of 20ml/minute and the columntemperature was maintained at 40°Cvia jacketing and a constant temperature bath. Columneffluent was monitored at 276 nm with a Gilson Model 116UV detector equipped with a 0.05-mm pathlength cell. TLC (Rf 0.53, ) and HPLCanalyses of the individual fractions were carried out as described in the "Antifungal, TLCand HPLC Assays" section. Fractions containing 1 were combined and extracted with an equal volume of CH2C12. The CH2C12layer was concentrated to yield approximately lOOmgof pure 1 as a colorless oil.
Some decomposition of the pure material, however, did occur with time and 40 mg of this preparation had to be further purified via a step gradient on silica gel (EtOAc-hexane-NH4OH (50:50:2), EtOAc-hexane-NH4OH (75:25:2), EtOAc-NH4OH (100:2)). Isolation of Restricticin (1) from Submerged Fermentation Three 1,400-liter scale fermentations yielded 2,600 liters of whole broth to which 1,300 liters of EtOAc was added. A 2-m potassium mono-hydrogenphosphate solution was then added until the pH of the aqueous phase was ca. 6.8 and the mixture was stirred for 1 hour. The EtOAcphase was then decanted via centrifugation and the spent broth reextracted with a second portion of EtOAc (1,060 liters). The two EtOAcextracts were combined and concentrated under reduced pressure to a volume of 480 liters. Hexane (475 liters) was added to the concentrated EtOAc extract, followed by 189 liters of dilute sulfuric acid in an aqueous MeOHsolution (13ml concentrated sulfuric acid per 100-liter methanol-water (1 : 1)). After 30 minutes stirring, the aqueous phase was collected. The acid extraction was repeated twice with two additional portions of dilute sulfuric acid in MeOHsolution (265 and 295 liters, respectively). All three aqueous extracts were combined to give 749 liters. The pH of the aqueous extract was adjusted to 6.8 by adding 18.9 liters of 1 m pH 7 potassium phosphate buffer. This aqueous extract was then back-extracted with three 235 liters portions of hexane. The combinedhexane extracts were concentrated under reduced pressure to a volume of 66 liters, containing 15.5g of 1.
The concentrated hexane extracts were then extracted with 0. 1 n hydrochloric acid in three portions (7.6 liters dilute HC1per 22.7-liter portion of concentrated hexane extract). The three acid extracts were combined and washed with 7.6 liters of hexane. The pH of the aqueous phase was then adjusted to 6.8 using 1 m pH 7 potassium phosphate buffer as described above. The neutralized aqueous phase was extracted with hexane (7.6 liters). MeOH(3.8 liters) was then added to the hexane extract. The MeOH layer, containing ca. 10g of 1, was collected and stored at -20°C.
*H NMRof this preparation indicated 1 with no obvious impurities, while HPLCindicated a few low-level impurities.
Isolation and Physical Characterization of A^iV-Dimethylrestricticin (2) from Solid Fermentation A series of CH2C12partitions were prepared from a variety of MeOHextracts of solid fermentations of P. restrictum prepared as previously described in the "Solid Fermentation" and "Isolation and Physical Characterization of Restricticin (1) from Solid Fermentation" sections. These partitions were combined and concentrated to yield 10.2g of an oil.
This concentrate was taken up in 300 ml of EtOAc -MeOH(75 : 25) and chromatographed on a 6-liter silica gel column (E. Merck, 60~200mesh) at 150ml/minute using a step gradient of EtOAc-hexane This oil was taken up in 20ml of EtOAc-hexane (1 : 1) to yield 15ml of supernatant and 5ml of precipitate. The supernatant was chromatographed on a 500-ml silica gel column using a step gradient of EtOAc-hexane (50 : 50), EtOAc, EtOAc-MeOH (90 : 10) and EtOAc-MeOH(75 : 25). The later fractions from the EtOAc elution were combined based on biological activity and TLC(Rf 0.79, CH2C12-MeOH (95 : 5)) and concentrated to yield 24mg of an oil. This concentrate was further purified via an additional step gradient on a 50-ml silica gel column. The active constituent again eluted with EtOAcand was concentrated to yield 1.5mg of pure 2. XH NMR (300MHz, CD2C12) <5ppm (JHH Hz) 0.90 3H t (7. Hydrolysis of Restricticin (1) to Restrictinol (3) Restrictinol (3) was produced via hydrolysis of 1 as described below. Fifty mg of 1 was dissolved in 5ml MeOHto which 500/il of a 1.0-m solution of NaOHwas added at room temperature with stirring. After stirring for 2 hours, 80ml of EtOAcand 40ml of water were added to the reaction mixture. The resulting layers were separated and the EtOAclayer was washed with another 40 ml of water. The organic layer was dried over Na2SO4and the solvents removed in vacuo. Aslightly yellow oil (34mg, 78%yield) was obtained, which exhibited a single spot by TLC (Rf 0.47, hexane-EtOAc (1 : 1) absorbance at 3420cm-1 for the alcohol that was generated and an absence of carbonyl absorbances.
Restrictinol was often isolated from these fermentations as a decomposition product of restricticin and, in fact, in manycases whole batches decomposedto restrictinol with little or no restricticin remaining.
Antifungal Activity: Agar Dilution Assay Ketoconazole and 1 were solubilized in 10%aqueous DMSO and diluted 2-fold in sterile distilled water. The two agars used for this study were yeast nitrogen base glucose agar and Kimmigagar. Each diluted drug was added to cooled, molten agar (1.0ml of drug plus 9.0ml of agar). Appropriate solvent and media controls (drug free) also were prepared. Prepared plates were stored in the dark at room temperature 18 hours prior to use. Drug concentrations tested ranged from 128~0.06 /ig/ml. All fungi used in the assay were from the Merck Culture Collection. The yeast cultures, maintained in yeast-maltose (YM) broth, were transferred to fresh YMmedium and incubated for 18 hours at 35°C with shaking (250rpm).
After incubation, each culture was diluted in sterile saline to yield final concentrations of 3 x 105 to 3 x 106 cfu/ml. The filamentous fungi {Aspergillus and Penicillium) were maintained on potato -glucose agar slants and spore suspensions perpared by washing spores from the agar surface with sterile distilled water. The spore preparations were used as the inocula for the filamentous fungi tested.
Each prepared plate was inoculated with the test organisms (18 yeasts and three filamentous fungi) using a Denley Multipoint Inoculator (Denley, Sussex, England), which delivers approximately 0.001 ml to the agar surface resulting in an inoculum of from 3 x 102 to 3 x 103 cfu. The plates were incubated at 30°C for 48 hours. The MICswere recorded as the lowest concentration of drug showing no growth or less than 3 cfu/spot
Results and Discussion Description of Producing Strain
The diagnostic microscopic features of the producing organism, P. restrictum, are illustrated in Fig. 2 . Colonies grown according to the method of Pitt8), exhibited the characteristics described in the following paragraphs. Conidiophores micronematousto semi-macronematous, monoverticilliate, without rami or metulae, unbranched, aseptate, straight to slightly curved, 15~28 x 2~4 /mi, with non-inflated to slightly inflated apices, arising directly from aerial mycelium. Phialides arising directly from conidiophore apices, ampulliform to cylindrical, tapered to a truncate apex, 5.5~8 x 2.5~3 /an, usually 3~5/conidiophore, but ranging 1~8/conidiophore. Conidia globose to subglobose, 3~3.5 /mi i.d., hyaline, smooth to faintly punctate, occasionally with faint traces of disjunctors, adhering to conidiophores in dry chains.
Fermentation
Original fermentations of culture MF 5261 (ATCC 20927) were performed on solid substrate medium contained in 250-ml Erlenmeyer flasks. Assay results on extracts of these flasks indicated the presence of a novel antifungal agent. Larger fermentations were required to obtain sufficient material for isolation and identification of the active constituent. Initial isolation of the active compound 1 was achieved from solid fermentations in trays. Sufficient material was isolated from solid fermentation for structural elucidation of 1, however, these fermentations nroved to be both cumbersome and inaoDroDriate 
Analysis
The original HPLC system I ( components. Adjusting the pH of the aqueous portion of the mobile phase to 2.5 using H3PO4in system III, in order to protonate the amine of 1, differentiated it from 3 (Rt 13.8 minutes), however, 1 did not elute after 30 minutes from the Zorbax ODScolumn. In its protonated form, 1 should have been significantly more polar than 3 and had a shorter Rt in the absence of interactions with the silica backbone. On a WhatmanODS3column, using an acidic mobile phase (system IV), 1 also had a longer Rt than 3, and a very poor peak shape, again suggesting interaction with exposed silica sites. On the other hand, 1 behaved radically different on a Zorbax RXcolumn, under acidic conditions (system V), with a significantly shorter Rt than 3, indicating little interaction with the silica sites. The most useful HPLCassay, from a practical point of view, was the DuPont Zorbax RX column CH3CN-0.01m potassium phosphate pH 7, 70: 30 (system II), since both compounds of interest had reasonable Rt's but were well resolved.
Stability of Restricticin The lack of stability of 1 severely complicated the isolation, storage and chemical manipulation of this molecule. Twomodes of instability were noted, i.e., the lability of the glycine ester towards base hydrolysis and the tendency of the triene functionality to decompose. The hydrolytic instability could be minimized by maintaining solutions of 1 at either neutral or acidic pH, while the decomposition of the side chain could be minimized by storing 1 in polar solvents like methanol and avoiding long-term storage in non-polar solvents like methylene chloride. It seems likely, in retrospect, that 3 is not a natural product, but results from the decomposition of 1. Isolation The original isolation from solid fermentation was essentially a race against the instability of 1. Several previous isolation attempts resulted in the loss of biological activity and the isolation of 3. Extraction of the solid fermentation, followed by partition into methylene chloride, repeated silica gel chromatographies and a final preparative reverse phase chromatography yielded sufficient material for structure determination, some chemical modification and biological evaluation.
A more rational isolation scheme was developed for the large scale liquid fermentation based on knowledgeof the structure and instability of 1. The basic isolation strategy was to makeuse of the amine functionality to extract and purify 1 from the fermentation broth, while avoiding conditions which favored its decomposition. Anacid/base extraction scheme appeared to be the easiest to implement on a pilot plant scale.
The whole broth (2,600 liters) was adjusted to pH 7 and extracted with ethyl acetate. A four solvent system was developed for optimal partitioning of 1 into the aqueous phase from the organic phase. The concentrated extract was thus diluted with hexane, and extracted with dilute sulfuric acid in aqueous methanol. The aqueous extract was then adjusted to pH 7 using potassium phosphate buffer, to prevent hydrolysis of the base labile glycyl ester, and extracted with hexane. After concentration of the hexane extract, the acid extraction -hexane back-extraction process was repeated. After a final partition into methanol, ca. 10g purified 1 was obtained. No chromatography steps were necessary.
Antifungal Activity The antifungal activities of 1 and ketoconazole in both yeast nitrogen base agar and Kimmigagar are shown in Table 2 .
